← Evidence map

ReviewExpert review of clinical pharmacology2018

PD-L1 inhibition with avelumab for metastatic Merkel cell carcinoma.

Maria Rita Gaiser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 29478343